Zhejiang CONBA Pharmaceutical Co Ltd (600572) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zhejiang CONBA Pharmaceutical Co Ltd (600572) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥133.43 Million ≈ $19.52 Million USD) by net assets (CN¥7.16 Billion ≈ $1.05 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 600572 stock market capitalisation for the company's overall valuation and market capitalisation.
Zhejiang CONBA Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2025)
This chart illustrates how Zhejiang CONBA Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Zhejiang CONBA Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang CONBA Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore cash flow quality index of Zhejiang CONBA Pharmaceutical Co Ltd to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Elang Mahkota Teknologi Tbk
JK:EMTK
|
-0.013x |
|
SFL Corporation Ltd
NYSE:SFL
|
0.035x |
|
Guizhou Aviation Technical Development Co Ltd
SHG:688239
|
-0.531x |
|
Luoyang Longhua Heat Trans Energy
SHE:300263
|
0.024x |
|
AeroSpace Technology of Korea
KQ:067390
|
0.020x |
|
CIE Automotive India Limited
NSE:CIEINDIA
|
0.172x |
|
Jiangsu Changfa Refrigeration Co Ltd
SHE:002413
|
0.000x |
|
AKSO HEALTH GR. (SPADR)/3
F:8HX
|
N/A |
Annual Cash Flow Conversion Efficiency for Zhejiang CONBA Pharmaceutical Co Ltd (2003–2025)
The table below shows the annual cash flow conversion efficiency of Zhejiang CONBA Pharmaceutical Co Ltd from 2003 to 2025. View Zhejiang CONBA Pharmaceutical Co Ltd stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥7.15 Billion ≈ $1.05 Billion |
CN¥942.61 Million ≈ $137.93 Million |
0.132x | -10.02% |
| 2024-12-31 | CN¥6.91 Billion ≈ $1.01 Billion |
CN¥1.01 Billion ≈ $148.16 Million |
0.146x | +19.80% |
| 2023-12-31 | CN¥7.35 Billion ≈ $1.08 Billion |
CN¥898.64 Million ≈ $131.50 Million |
0.122x | -22.50% |
| 2022-12-31 | CN¥7.32 Billion ≈ $1.07 Billion |
CN¥1.16 Billion ≈ $169.08 Million |
0.158x | +31.05% |
| 2021-12-31 | CN¥7.39 Billion ≈ $1.08 Billion |
CN¥889.94 Million ≈ $130.23 Million |
0.120x | -48.47% |
| 2020-12-31 | CN¥5.35 Billion ≈ $782.79 Million |
CN¥1.25 Billion ≈ $182.87 Million |
0.234x | +24.76% |
| 2019-12-31 | CN¥4.94 Billion ≈ $723.27 Million |
CN¥925.50 Million ≈ $135.43 Million |
0.187x | +98.73% |
| 2018-12-31 | CN¥5.79 Billion ≈ $847.64 Million |
CN¥545.78 Million ≈ $79.86 Million |
0.094x | -22.70% |
| 2017-12-31 | CN¥5.84 Billion ≈ $855.11 Million |
CN¥712.27 Million ≈ $104.23 Million |
0.122x | -43.59% |
| 2016-12-31 | CN¥4.49 Billion ≈ $656.77 Million |
CN¥969.71 Million ≈ $141.90 Million |
0.216x | +18.66% |
| 2015-12-31 | CN¥4.57 Billion ≈ $668.05 Million |
CN¥831.26 Million ≈ $121.64 Million |
0.182x | -0.61% |
| 2014-12-31 | CN¥3.37 Billion ≈ $493.18 Million |
CN¥617.43 Million ≈ $90.35 Million |
0.183x | +101.72% |
| 2013-12-31 | CN¥2.59 Billion ≈ $379.22 Million |
CN¥235.36 Million ≈ $34.44 Million |
0.091x | -9.81% |
| 2012-12-31 | CN¥2.44 Billion ≈ $357.14 Million |
CN¥245.76 Million ≈ $35.96 Million |
0.101x | -13.82% |
| 2011-12-31 | CN¥1.61 Billion ≈ $235.90 Million |
CN¥188.36 Million ≈ $27.56 Million |
0.117x | +59.22% |
| 2010-12-31 | CN¥1.72 Billion ≈ $251.12 Million |
CN¥125.93 Million ≈ $18.43 Million |
0.073x | -45.11% |
| 2009-12-31 | CN¥1.15 Billion ≈ $167.90 Million |
CN¥153.39 Million ≈ $22.45 Million |
0.134x | +24.75% |
| 2008-12-31 | CN¥919.66 Million ≈ $134.58 Million |
CN¥98.56 Million ≈ $14.42 Million |
0.107x | +14.52% |
| 2007-12-31 | CN¥854.74 Million ≈ $125.08 Million |
CN¥79.98 Million ≈ $11.70 Million |
0.094x | -17.51% |
| 2006-12-31 | CN¥627.66 Million ≈ $91.85 Million |
CN¥71.20 Million ≈ $10.42 Million |
0.113x | -42.62% |
| 2005-12-31 | CN¥595.08 Million ≈ $87.08 Million |
CN¥117.65 Million ≈ $17.22 Million |
0.198x | +70.62% |
| 2004-12-31 | CN¥565.05 Million ≈ $82.68 Million |
CN¥65.47 Million ≈ $9.58 Million |
0.116x | -58.37% |
| 2003-12-31 | CN¥239.44 Million ≈ $35.04 Million |
CN¥66.64 Million ≈ $9.75 Million |
0.278x | -- |
About Zhejiang CONBA Pharmaceutical Co Ltd
Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of pharmaceuticals and health products in mainland China. It offers medicines, Chinese patent medicines, chemical medicines, Chinese herbal medicine slices, and health products. The company also provides Chinese decoction pieces; over-the-counter medications; healthy consumer products, including nut… Read more